Quaker Chemical Corporation filings document Quaker Houghton's industrial process fluids business, operating results and corporate governance as the NYSE-listed issuer behind KWR. Form 8-K reports include quarterly financial results, supplemental information, credit agreement amendments, senior secured term loan and revolving credit facility disclosures, and officer compensation or separation arrangements.
Proxy materials cover director elections, executive compensation, equity awards, shareholder voting matters and governance practices. Material-agreement filings also describe borrower and subsidiary arrangements, lender relationships, debt facilities and related capital-structure terms for the company.
Quaker Chemical Corporation reported higher results for the first quarter of 2026, with net sales of $480.5 million, up 8% from $442.9 million a year earlier. Growth came from roughly 3% higher organic volumes, about 4% from acquisitions, and a 4% favorable currency impact, partly offset by a 3% decline in selling price and product mix.
Net income rose to $19.7 million, or $1.13 diluted EPS, from $12.9 million, or $0.73, while non-GAAP net income was $28.4 million and non-GAAP diluted EPS was $1.63 versus $28.0 million and $1.58. Adjusted EBITDA increased to $72.5 million from $69.0 million as gross margin improved to 36.8%. Operating cash flow turned positive at $3.8 million versus a $3.1 million outflow, and cash ended at $169.7 million against total borrowings of $875.0 million. The company launched a 2026 global business transformation program targeting at least $20–$30 million of annualized cost savings, while continuing its 2022 cost program, and noted that Middle East geopolitical tensions have not yet had a material financial impact but pose ongoing supply chain and cost risks.
Quaker Houghton reported stronger first-quarter 2026 results with higher sales and profit. Net sales were $480.5 million, up 8% from $442.9 million a year earlier, helped by 3% higher volumes, 4% growth from acquisitions and favorable currency, partly offset by lower pricing and mix.
Net income rose to $19.7 million, or $1.13 per diluted share, compared with $12.9 million, or $0.73 per share, while non-GAAP net income was $28.4 million and non-GAAP diluted EPS was $1.63, slightly above $1.58 last year. Adjusted EBITDA increased 5% to $72.5 million.
Asia/Pacific led growth with 25% higher sales, EMEA grew 10% and Americas was flat year over year. Operating cash flow improved to $3.8 million from a $3.1 million outflow. The company ended March 31, 2026 with $875.0 million of gross debt, $169.7 million of cash and a net debt-to-trailing adjusted EBITDA ratio of about 2.3x.
Quaker Houghton amended its credit agreement after quarter-end, extending the nearest maturity to 2031 and increasing available credit, and launched a global transformation and cost program targeting $20 million to $30 million of annualized savings by 2028, with a $10 million run-rate goal by the end of 2026.
Quaker Chemical Corp ownership disclosure: Vanguard Portfolio Management reports beneficial ownership of 934,704 shares of Common Stock, representing 5.39% of the class as of 03/31/2026. Vanguard shows sole dispositive power over 934,704 shares and sole voting power for 5,291 shares, and states holdings include shares held for Vanguard funds and managed accounts.
Quaker Houghton entered into an amended senior secured credit agreement that refinances its existing facilities, extends debt maturities and increases available borrowing capacity. The new package includes a $550 million U.S. dollar term loan, a $250 million-equivalent euro term loan and an $800 million revolving credit facility, all maturing in 2031. Proceeds repaid the prior credit agreement and support working capital, strategic growth and other capital allocation plans. The facility is secured by first‑priority liens on substantially all assets of the company and certain subsidiaries, and includes leverage and interest coverage covenants plus limits on additional debt, acquisitions, dividends, buybacks and other restricted payments.
Meagher Kevin K. reported acquisition or exercise transactions in this Form 4 filing.
Quaker Chemical Corp VP Kevin K. Meagher reported an amended insider transaction reflecting a compensation grant of 445 Restricted Stock Units (RSUs) tied to the company’s common stock. This corrects a previously reported grant of 297 RSUs. Each RSU represents a contingent right to receive one share of KWR common stock.
The RSUs were granted under the company’s Long-Term Performance Incentive Plan and will vest in three annual installments beginning on March 15, 2027. Dividend Equivalent Rights accrue on these RSUs when and as dividends are paid on Quaker Chemical common stock.
Frodl Andre reported acquisition or exercise transactions in this Form 4 filing.
Quaker Chemical Corporation reported that VP of R&D–Metals & Metalworking Andre Frodl received a grant of 724 Restricted Stock Units (RSUs) on March 15, 2026 under the company’s Long-Term Performance Incentive Plan. An earlier Form 4 had mistakenly shown 371 RSUs. Each RSU represents one share of KWR common stock, with Dividend Equivalent Rights accruing when dividends are paid. The RSUs will vest in three annual installments beginning on March 15, 2027.
Quaker Houghton is soliciting proxies for its 2026 virtual annual meeting, where shareholders will elect three directors, vote on a non-binding say-on-pay proposal, and ratify PricewaterhouseCoopers LLP as independent auditor for 2026.
The meeting will be held online on May 13, 2026 at 8:00 a.m. Eastern via www.virtualshareholdermeeting.com/KWR2026, with voting available by internet, phone, mail, or during the webcast. Shareholders of record at the close of business on March 2, 2026 may vote, representing up to 17,335,077 shares of common stock.
The board, currently composed of eleven directors, recommends voting FOR all three proposals. It highlights a majority-independent structure, separation of Chair and CEO roles, dedicated risk and sustainability oversight, and a board of which 45% self-identify as women or persons of color.
Quaker Chemical Corp: The Vanguard Group filed an amended Schedule 13G/A reporting that it beneficially owns 0 shares of Quaker Chemical Corp common stock, representing 0% of the class. The filing explains an internal realignment effective January 12, 2026, under SEC Release No. 34-39538 that caused certain Vanguard subsidiaries or divisions to report beneficial ownership separately.
Quaker Chemical Corp senior vice president, general counsel and corporate secretary Robert T. Traub reported a series of equity compensation transactions on March 15, 2026.
He received 1,772 time-based restricted stock units and 1,028 shares of common stock earned from performance stock units granted in 2023, following certification of the company’s adjusted return on invested capital performance. Previously granted RSUs and dividend equivalent rights were also converted into common stock.
In connection with these vestings, 562 shares of common stock were surrendered at $118.45 per share to cover withholding taxes, a non‑market disposition. After these transactions, Traub directly holds 4,351 shares of common stock, and indirectly holds 1,262 shares through a 401(k) plan as of December 31, 2025.
Quaker Chemical’s SVP and Chief Human Resources Officer Kristin Rokosky reported routine equity compensation activity. On March 15, 2026, performance stock units and restricted stock units vested and were settled into 487 shares of common stock, with additional shares from dividend equivalent rights, and she also received a new grant of 1,350 time-based RSUs that vest in three annual installments beginning March 15, 2027. In connection with these vestings, she was awarded 80 shares of common stock and then on March 16, 2026 surrendered 177 shares at $118.45 per share to cover withholding taxes. Following these transactions, Rokosky directly holds 1,109 shares of Quaker Chemical common stock, while the newly granted RSUs represent additional contingent future equity.